Manufacturer Compliance Programs For Medicare Advocated By Prosecutor
Executive Summary
The establishment of a Medicare prescription drug benefit should trigger the creation of Medicare compliance programs within pharmaceutical companies, Philadelphia Assistant U.S. Attorney James Sheehan said.
You may also be interested in...
PBM Prosecution May Rely On Adverse Event From Rx Switch - FDLI Panel
A serious adverse event associated with a therapeutic switch may be the trigger for a case to emerge from the ongoing Philadelphia grand jury investigation of PBM practices, panelists suggested during a Food & Drug Law Institute/Health Care Compliance Association meeting in Washington, D.C. Oct. 18.
PBM Prosecution May Rely On Adverse Event From Rx Switch - FDLI Panel
A serious adverse event associated with a therapeutic switch may be the trigger for a case to emerge from the ongoing Philadelphia grand jury investigation of PBM practices, panelists suggested during a Food & Drug Law Institute/Health Care Compliance Association meeting in Washington, D.C. Oct. 18.
PBM Standards Allow Preparation Of Formulary Reviews For P&T Committee
Pharmacy benefit management standards developed by the trade association PCMA allow PBMs to provide an initial formulary review to an independent pharmacy and therapeutics committee.